Publicacións en colaboración con investigadores/as de Karolinska Institute (5)

2018

  1. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia

    Brain, Behavior, and Immunity, Vol. 67, pp. 139-151

2014

  1. Birthweight and the risk of atopic diseases: The ISAAC Phase III study

    Pediatric Allergy and Immunology, Vol. 25, Núm. 3, pp. 264-270

2013

  1. Renal effects of levosimendan: A consensus report

    Cardiovascular Drugs and Therapy, Vol. 27, Núm. 6, pp. 581-590

2011

  1. Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6-7 year old children: ISAAC Phase Three

    Allergologia et Immunopathologia, Vol. 39, Núm. 6, pp. 318-325

2008

  1. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme

    The Lancet, Vol. 372, Núm. 9643, pp. 1039-1048